SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies
Investors of Class Action Against Genocea Bioscience, Inc. (GNCA) &
Lead Plaintiff Deadline: January 2, 2018
NEW YORK, Nov. 1, 2017 /PRNewswire/ -- Attorney Advertising --
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class
action lawsuit has been filed against Genocea Bioscience, Inc.
("Genocea" or the "Company") (NASDAQ: GNCA) and
certain of its officers, on behalf of a class who purchased or
otherwise acquired Genocea securities between May 5, 2017 and September
25, 2017, both dates inclusive (the "Class Period"). Such investors are
encouraged to join this case by visiting the firm's site: www.bgandg.com/gnca.
This class action seeks to recover damages against Defendants for
alleged violations of the federal securities laws under the Securities
Exchange Act of 1934.
The Complaint alleges that throughout the Class Period, Defendants made
materially false and/or misleading statements and/or failed to disclose
that: (1) Genocea's finances were insufficient to support Phase 3
trials of GEN-003; (2) as a result, Genocea had overstated the
prospects for GEN-003; and (3) consequently, Genocea's public
statements were materially false and misleading at all relevant times.
On September 25, 2017, after market-hours, Genocea revealed that it was
halting spending and activities on GEN-003 and exploring strategic
alternatives for the drug, and that it was cutting 40% of its
workforce. Following this news, Genocea stock dropped $4.08 per share,
or 76.5%, to close at $1.25 on September 26, 2017.
A class action lawsuit has already been filed. If you wish to review a
copy of the Complaint you can visit the firm's site:
www.bgandg.com/gnca or you may contact Peretz Bronstein, Esq. or
his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz
& Grossman, LLC at 212-697-6484. If you suffered a loss in Genocea
you have until January 2, 2018 to request that the Court appoint you as
lead plaintiff. Your ability to share in any recovery doesn't
require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class action
security litigation, the firm's expertise includes general corporate
and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright 2017 Ernstrade